Literature DB >> 1429830

Drug resistance in oncology: from concepts to applications.

J L Cazin, P Gosselin, P Cappelaere, J Robert, A Demaille.   

Abstract

The complex problem of drug resistance is discussed with respect to host toxicity, to tumor characteristics (kinetic resistance, heterogeneity of cell subpopulations, hypoxia, mutation and gene amplification), and to the medication itself (pharmacokinetic and pharmacodynamic resistance: cell membrane, intracellular metabolism, intracellular target). After detailing each type of resistance, the possibilities of fighting against drug resistance are explored (dealing with host toxicity, tumor characteristics and drugs--intensifying therapy, multiple drug therapy, biochemical modulation, particular modalities of drug administration). Finally, perspectives of research and development of new drugs are summarized.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429830     DOI: 10.1007/bf01209660

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  82 in total

Review 1.  Drug resistance, the last frontier?

Authors:  J A Kellen
Journal:  Anticancer Res       Date:  1991 Mar-Apr       Impact factor: 2.480

2.  Multidrug resistance: molecular biology and clinical relevance.

Authors:  M Rothenberg; V Ling
Journal:  J Natl Cancer Inst       Date:  1989-06-21       Impact factor: 13.506

3.  Rationale for the use of alternating non-cross-resistant chemotherapy.

Authors:  J H Goldie; A J Coldman; G A Gudauskas
Journal:  Cancer Treat Rep       Date:  1982-03

4.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

5.  Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance.

Authors:  B C Baguley; K M Holdaway; L M Fray
Journal:  J Natl Cancer Inst       Date:  1990-03-07       Impact factor: 13.506

6.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.

Authors:  J R Riordan; K Deuchars; N Kartner; N Alon; J Trent; V Ling
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

7.  Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.

Authors:  J M Trent; R N Buick; S Olson; R C Horns; R T Schimke
Journal:  J Clin Oncol       Date:  1984-01       Impact factor: 44.544

8.  Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

Authors:  G D Pennock; W S Dalton; W R Roeske; C P Appleton; K Mosley; P Plezia; T P Miller; S E Salmon
Journal:  J Natl Cancer Inst       Date:  1991-01-16       Impact factor: 13.506

9.  Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.

Authors:  H Herweijer; P Sonneveld; F Baas; K Nooter
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

10.  Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.

Authors:  I Fabre; G Fabre; I D Goldman
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

View more
  1 in total

1.  Modulation of doxorubicin-toxicity by tamoxifen in multidrug-resistant tumor cells in vitro and in vivo.

Authors:  E Pommerenke; J Mattern; M Volm
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.